For: | Mori H, Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol 2020; 26(15): 1733-1744 [PMID: 32351290 DOI: 10.3748/wjg.v26.i15.1733] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i15/1733.htm |
Number | Citing Articles |
1 |
Toshihiro Nishizawa, Kosuke Sakitani, Hidekazu Suzuki, Shuntaro Yoshida, Yosuke Kataoka, Yousuke Nakai, Hirotoshi Ebinuma, Takanori Kanai, Osamu Toyoshima, Kazuhiko Koike. Clinical features of cardiac nodularity-like appearance induced by <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2020; 26(35): 5354-5361 doi: 10.3748/wjg.v26.i35.5354
|
2 |
Sooyoun Park, Eunsol Yang, Byungwook Kim, Jihoon Kwon, In‐Jin Jang, Seung Hwan Lee. Pharmacokinetic and pharmacodynamic exploration of various combinations of tegoprazan immediate and delayed‐release formulations. British Journal of Clinical Pharmacology 2023; 89(9): 2877 doi: 10.1111/bcp.15784
|
3 |
Guner Kilic, Gulce Ecem Kilic, Adnan Özkahraman, Sevki Konur, Ramazan Dertli, Yusuf Kayar. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study. Medicine 2024; 103(18): e38012 doi: 10.1097/MD.0000000000038012
|
4 |
Hideki Mori, Hidekazu Suzuki.
Cutting-edge insights into
Helicobacter
research
. Free Radical Research 2024; 58(10): 641 doi: 10.1080/10715762.2024.2421174
|
5 |
Hidekazu Suzuki, Hideki Mori. Single‐capsule bismuth quadruple therapy: preferable at the moment, but what should be next?. United European Gastroenterology Journal 2021; 9(1): 7 doi: 10.1177/2050640620975357
|
6 |
|
7 |
Toshihiro Nishizawa, Munkhbayar Munkjargal, Hirotoshi Ebinuma, Osamu Toyoshima, Hidekazu Suzuki. Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review. Journal of Clinical Medicine 2021; 10(12): 2722 doi: 10.3390/jcm10122722
|
8 |
E. A. Ortenberg, M. V. Lyapina, E. F. Dorodnyeva. Competitive proton pump inhibitors - status and Prospects of use. Experimental and Clinical Gastroenterology 2023; (4): 86 doi: 10.31146/1682-8658-ecg-212-4-86-92
|
9 |
Inna A. Oganezova, Liya N. Belousova, Igor G. Bakulin. Modern approaches to the eradication of <i>Helicobacter pylori</i>: a spectrum of perspectives. Russian Family Doctor 2024; 28(3): 24 doi: 10.17816/RFD634209
|
10 |
V. Т. Ivashkin, I. V. Mayev, Р. V. Tsarkov, М. Р. Korolev, D. N. Andreev, Е. К. Baranskaya, D. S. Bordin, S. G. Burkov, А. А. Derinov, S. К. Efetov, Т. L. Lapina, Р. V. Pavlov, S. S. Pirogov, Е. А. Poluektova, А. V. Tkachev, А. S. Trukhmanov, А. I. Uljanin, Е. D. Fedorov, А. А. Sheptulin. Diagnostics and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, the Russian Society of Colorectal Surgeons, the Russian Endoscopic Society and the Scientific Society for the Clinical Study of Human Microbiome). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(2): 101 doi: 10.22416/1382-4376-2024-34-2-101-131
|
11 |
Pedro Vieira de Moraes Andrade, Yan Mosca Monteiro, Ethel Zimberg Chehter. Third-line and rescue therapy for refractory <i>Helicobacter pylori</i> infection: A systematic review. World Journal of Gastroenterology 2023; 29(2): 390-409 doi: 10.3748/wjg.v29.i2.390
|
12 |
Javaria Amil, Saadia Sajjad, Rida Ajmal Khan, Sadia Majeed, Khalil Ahmed, Muhammad Adnan Masood. Comparison of Therapeutic Outcomes: Two Triple-Therapy Approaches for H. pylori Eradication in Gastric Ulcer Disease. Pakistan Journal of Health Sciences 2024; : 142 doi: 10.54393/pjhs.v5i07.1850
|
13 |
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study. Antibiotics 2021; 10(10): 1242 doi: 10.3390/antibiotics10101242
|
14 |
Su Young Kim, Jun-Won Chung. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics 2020; 9(8): 436 doi: 10.3390/antibiotics9080436
|
15 |
V. T. Ivashkin, T. L. Lapina, I. V. Maev, O. M. Drapkina, R. S. Kozlov, A. A. Sheptulin, A. S. Trukhmanov, S. R. Abdulkhakov, O. P. Alekseeva, S. A. Alekseenko, D. N. Andreev, D. S. Bordin, N. N. Dekhnich, I. L. Klyaritskaya, N. V. Korochanskaya, M. F. Osipenko, E. A. Poluektova, A. S. Sarsenbaeva, V. I. Simanenkov, A. V. Tkachev, A. I. Ulyanin, I. B. Khlynov, V. V. Tsukanov. Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for <i>H. pylori</i> Diagnostics and Treatment in Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6): 72 doi: 10.22416/1382-4376-2022-32-6-72-93
|
16 |
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
|
17 |
Vincenzo De Francesco, Angelo Zullo, Raffaele Manta, Luigi Gatta, Giulia Fiorini, Ilaria M. Saracino, Dino Vaira. Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e66 doi: 10.1097/MEG.0000000000002100
|
18 |
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar. Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut 2022; 71(9): 1724 doi: 10.1136/gutjnl-2022-327745
|
19 |
Jinnan Chen, Puheng Li, Yu Huang, Yixian Guo, Zhaohui Ding, Hong Lu. Primary Antibiotic Resistance of Helicobacter pylori in Different Regions of China: A Systematic Review and Meta-Analysis. Pathogens 2022; 11(7): 786 doi: 10.3390/pathogens11070786
|